Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses

scientific article published on 19 June 2005

Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NG1583
P698PubMed publication ID15965477
P5875ResearchGate publication ID7778844

P2093author name stringKarla Kirkegaard
Scott Crowder
P2860cites workIdentification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPgQ24524070
Identification of a cis-acting replication element within the poliovirus coding regionQ24525105
5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesisQ24545690
The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesisQ27619999
Human rhinovirus 14 complexed with antiviral compound R 61837Q27650582
Structure of the RNA-dependent RNA polymerase of poliovirusQ27744366
Site-directed mutagenesis by overlap extension using the polymerase chain reactionQ27860503
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drugQ28360421
RNA virus mutations and fitness for survivalQ29619434
Conservation and prediction of solvent accessibility in protein familiesQ30419557
Poliovirus 5'-terminal cloverleaf RNA is required in cis for VPg uridylylation and the initiation of negative-strand RNA synthesisQ33848778
MATURATION OF POLIOVIRUS RNA WITH CAPSID PROTEIN CODED BY HETEROLOGOUS ENTEROVIRUSESQ34407284
RESCUE OF DRUG-REQUIRING AND DRUG-INHIBITED ENTEROVIRUSESQ34418186
Poliovirus CRE-dependent VPg uridylylation is required for positive-strand RNA synthesis but not for negative-strand RNA synthesisQ34856873
Functional Dissection of a Poliovirus cis -Acting Replication Element [PV- cre (2C)]: Analysis of Single- and Dual- cre Viral Genomes and Proteins That Bind Specifically to PV- cre RNAQ34975487
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirusQ35994662
trans rescue of a mutant poliovirus RNA polymerase functionQ36689121
Temperature-sensitive poliovirus mutant fails to cleave VP0 and accumulates provirionsQ36782445
Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirusQ36797358
Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavageQ36831732
Construction and characterization of poliovirus subgenomic repliconsQ36866871
Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2AQ37274113
Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymeraseQ37513764
Functional inactivation of genes by dominant negative mutationsQ38178605
Identification of essential amino acid residues in the functional activity of poliovirus 2A proteaseQ38335028
Oligomeric structures of poliovirus polymerase are important for functionQ39714853
Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.Q39869070
Coupling between genome translation and replication in an RNA virusQ41454910
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.Q42028125
Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3BQ43492068
Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants.Q54097437
Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.Q54355016
A point mutation in the poliovirus polymerase gene determines a complementable temperature-sensitive defect of RNA replicationQ69328799
Visualization and functional analysis of RNA-dependent RNA polymerase latticesQ74335484
Mixed infection of HeLa cells with polioviruses types 1 and 2Q79056437
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)701-709
P577publication date2005-06-19
P1433published inNature GeneticsQ976454
P1476titleTrans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses
P478volume37

Reverse relations

cites work (P2860)
Q42546287A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle
Q36172158A vesiculovirus showing a steepened transcription gradient and dominant trans-repression of virus transcription
Q43281437Amino acid substitutions within the 2C coding sequence of Theiler's Murine Encephalomyelitis virus alter virus growth and affect protein distribution
Q38760904An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases
Q37491440Arenavirus genetic diversity and its biological implications
Q38064285Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions
Q38743913Attenuation of RNA viruses by redirecting their evolution in sequence space
Q34481724Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain
Q37966479Broad action of Hsp90 as a host chaperone required for viral replication
Q39707385Cell density-dependent expression of viral antigens during persistence of foot-and-mouth disease virus in cell culture
Q37252922Cellular mRNA decay protein AUF1 negatively regulates enterovirus and human rhinovirus infections
Q48078122Characterization of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications.
Q24649975Cis-acting RNA elements in human and animal plus-strand RNA viruses
Q37217217Cis-active RNA elements (CREs) and picornavirus RNA replication
Q33524705Competition-colonization dynamics in an RNA virus
Q42145287Competition-colonization dynamics: An ecology approach to quasispecies dynamics and virulence evolution in RNA viruses
Q57469924Contribution of a Multifunctional Polymerase Region of Foot-and-Mouth Disease Virus to Lethal Mutagenesis
Q53596573Defining residues involved in human rhinovirus 2A proteinase substrate recognition.
Q64896239Detection and Differentiation of Multiple Viral RNAs Using Branched DNA FISH Coupled to Confocal Microscopy and Flow Cytometry.
Q27681334Distinct Conformations of a Putative Translocation Element in Poliovirus Polymerase
Q34729490Dominant drug targets suppress the emergence of antiviral resistance
Q38613434Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization.
Q39062490During Infection, Theiler's Virions Are Cleaved by Caspases and Disassembled into Pentamers
Q52655516Emergency Services of Viral RNAs: Repair and Remodeling.
Q33611610Enzymatic and nonenzymatic functions of viral RNA-dependent RNA polymerases within oligomeric arrays
Q35589164Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance
Q24288775Exploiting Genetic Interference for Antiviral Therapy
Q33606983Exploration of sequence space as the basis of viral RNA genome segmentation
Q40199734Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe
Q56957412From Quasispecies Theory to Viral Quasispecies: How Complexity has Permeated Virology
Q33455562Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication.
Q27681313HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell
Q27468563Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle
Q28546101Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins
Q33898138Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease
Q84561053Identification of mutations conferring 5-azacytidine resistance in bacteriophage Qβ
Q24817069Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice
Q40087112Interstitial contacts in an RNA-dependent RNA polymerase lattice
Q38961370Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space
Q35382314Mechanisms controlling virulence thresholds of mixed viral populations
Q34326649Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population
Q41896864Mutagenesis-mediated virus extinction: virus-dependent effect of viral load on sensitivity to lethal defection
Q40326740Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag.
Q56957525Mutant spectra in virus behavior
Q36281122Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.
Q28076138My Cousin, My Enemy: quasispecies suppression of drug resistance
Q24607711NMR solution structure of poliovirus uridylyated peptide linked to the genome (VPgpU)
Q39969343No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus
Q35581640Non-template functions of viral RNA in picornavirus replication
Q28392368Pathogenesis of noroviruses, emerging RNA viruses
Q39603158Polyprotein-Driven Formation of Two Interdependent Sets of Complexes Supporting Hepatitis C Virus Genome Replication
Q28471847Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections
Q37691838Practical application of bioinformatics by the multidisciplinary VIZIER consortium
Q90209929Propensity of a picornavirus polymerase to slip on potyvirus-derived transcriptional slippage sites
Q56957250Quasispecies and Drug Resistance
Q48110822Quasispecies and virus.
Q34030011Quasispecies as a matter of fact: viruses and beyond.
Q45324684RNA Virus Evolution via a Quasispecies-Based Model Reveals a Drug Target with a High Barrier to Resistance
Q33279597Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50
Q57040745Rare haplotype load as marker for lethal mutagenesis
Q38675786Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein
Q46577714Resistance is futile
Q40693212Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C).
Q38761379Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication
Q24545889Silencing of hepatitis A virus infection by small interfering RNAs
Q36431588Suppression of Drug Resistance in Dengue Virus
Q57049926Targeting intramolecular proteinase NS2B/3 cleavages for -dominant inhibition of dengue virus
Q45323695The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers
Q38199555The leader proteinase of foot-and-mouth disease virus: structure-function relationships in a proteolytic virulence factor
Q38092577The role of mutational robustness in RNA virus evolution
Q52339521Transmission genetics of drug-resistant hepatitis C virus.
Q36607028Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections
Q38396578Viral quasispecies
Q86320171Viral quasispecies
Q27013917Viral quasispecies evolution
Q64956414Why viruses sometimes disperse in groups?†.

Search more.